MUC1 Expression in Papillary Thyroid Carcinoma Is Associated with BRAF Mutation and Lymph Node Metastasis; the Latter is the Most Important Risk Factor of Relapse-Reference-Cited by-同舟云学术

MUC1 Expression in Papillary Thyroid Carcinoma Is Associated with BRAF Mutation and Lymph Node Metastasis; the Latter is the Most Important Risk Factor of Relapse

Published:2014-09 Issue:9 Volume:24 Page:1375-1384
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Renaud Florence¹²³,Gnemmi Viviane¹²³,Devos Patrick³⁴,Aubert Sébastien¹²³,Crépin Michel⁵,Coppin Lucie²³⁵,Ramdane Nassima⁴,Bouchindhomme Brigitte¹,d'Herbomez Michelle³⁶,Van Seuningen Isabelle²³⁷,Do Cao Christine⁸,Pattou François³⁹¹⁰,Carnaille Bruno³⁹,Pigny Pascal²³⁵,Wémeau Jean-Louis³⁸,Leteurtre Emmanuelle¹²³

Affiliation:

1. Institute of Pathology, Lille University Hospital, Lille, France.

2. Inserm, UMR837, team 5 “Mucins, epithelial differentiation and carcinogenesis,” Jean-Pierre Aubert Research Center, Lille, France.

3. Faculty of Medicine, North of France University, Lille, France.

4. Department of Research, EA2694, Lille University Hospital, Lille, France.

5. Molecular Oncology and Genetics, Lille University Hospital, Lille, France.

6. Nuclear Medicine, Biology Pathology Center, Lille University Hospital, Lille, France.

7. Department of Digestive Surgery, Lille University Hospital, Lille, France.

8. Endocrinology and Metabolic Diseases, Lille University Hospital, Lille, France.

9. Endocrine Surgery, Hopital Claude Huriez; Lille University Hospital, Lille, France.

10. Inserm, UMR859, “Diabetes Biotherapy,” Lille, France.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2013.0594

Reference62 articles.

1. DeLellisRA, LloydRV, HeitzPU, EngC (eds) 2004 World Health Organization Classification of Tumors Pathology and Genetics of Tumors of Endocrine Organs. IARC Press, Lyon.

2. Changing Patterns in the Incidence and Survival of Thyroid Cancer with Follicular Phenotype—Papillary, Follicular, and Anaplastic: A Morphological and Epidemiological Study

3. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

4. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce

5. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galactia lindenii lectin type-II. Proposal of its potential use in diagnostic tools;2024-05-22

2. CA19-9 producing locally advanced papillary thyroid carcinoma: a case report;Surgical Case Reports;2024-04-10

3. Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

4. Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability;Oncogene;2022-10-17

5. Amphicrine Medullary Thyroid Carcinoma — a Case-Based Review Expanding on Its MUC Expression Profile;Endocrine Pathology;2022-06-23